speb/financial-data huggingface dataset:
PGEL.NS income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 208323000.00
PGEL.NS income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
PGEL.NS income_statement (quarterly, 2025-06-30) — Tax Provision: 179711000.00
PGEL.NS income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.21
PGEL.NS income_statement (quarterly, 2025-06-30) — Total Expenses: 14034454000.00
PGEL.NS income_statement (quarterly, 2025-09-30) — +Operating Expense: 1333497000.00
PGEL.NS income_statement (quarterly, 2025-09-30) — +Total Revenue: 6553661000.00
PGEL.NS balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 7808785000.00
PGEL.NS balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 6132746000.00
PGEL.NS balance_sheet (quarterly, 2025-09-30) — Available For Sale Securities: 329825000.00
PGEL.NS income_statement (quarterly, 2025-09-30) — Basic Average Shares: 306644444.00
PGEL.NS income_statement (quarterly, 2025-09-30) — Basic EPS: 0.09
PGEL.NS balance_sheet (quarterly, 2025-09-30) — Capital Lease Obligations: 1069321000.00
PGEL.NS balance_sheet (quarterly, 2025-09-30) — Capital Stock: 284076000.00
PGEL.NS balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 451822000.00
PGEL.NS balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 6679701000.00
PGEL.NS balance_sheet (quarterly, 2025-09-30) — Common Stock: 284076000.00
PGEL.NS balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 29021377000.00
PGEL.NS balance_sheet (quarterly, 2025-09-30) — Construction In Progress: 2245355000.00
PGEL.NS income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 5135674000.00
PGEL.NS balance_sheet (quarterly, 2025-09-30) — Current Assets: 29443823000.00
PGEL.NS balance_sheet (quarterly, 2025-09-30) — Current Capital Lease Obligation: 228055000.00
PGEL.NS balance_sheet (quarterly, 2025-09-30) — Current Debt: 3109973000.00
PGEL.NS balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 3338028000.00
PGEL.NS balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 14286937000.00
PGEL.NS balance_sheet (quarterly, 2025-09-30) — Current Provisions: 25112000.00
PGEL.NS income_statement (quarterly, 2025-09-30) — Depreciation And Amortization In Income Statement: 216458000.00
PGEL.NS income_statement (quarterly, 2025-09-30) — Depreciation Income Statement: 216458000.00
PGEL.NS income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 306644444.00
PGEL.NS income_statement (quarterly, 2025-09-30) — Diluted EPS: 0.09
PGEL.NS income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: 27598000.00
PGEL.NS income_statement (quarterly, 2025-09-30) — EBIT: 230345000.00
PGEL.NS income_statement (quarterly, 2025-09-30) — EBITDA: 446803000.00
PGEL.NS balance_sheet (quarterly, 2025-09-30) — Goodwill: 34000.00
PGEL.NS balance_sheet (quarterly, 2025-09-30) — Goodwill And Other Intangible Assets: 70889000.00
PGEL.NS balance_sheet (quarterly, 2025-09-30) — Gross PPE: 14310931000.00
PGEL.NS income_statement (quarterly, 2025-09-30) — Gross Profit: 1417987000.00
PGEL.NS income_statement (quarterly, 2025-09-30) — Interest Expense: 167129000.00
PGEL.NS income_statement (quarterly, 2025-09-30) — Interest Expense Non Operating: 167129000.00
PGEL.NS balance_sheet (quarterly, 2025-09-30) — Inventory: 13637588000.00
PGEL.NS balance_sheet (quarterly, 2025-09-30) — Invested Capital: 33856710000.00
PGEL.NS balance_sheet (quarterly, 2025-09-30) — Investmentin Financial Assets: 329825000.00
PGEL.NS balance_sheet (quarterly, 2025-09-30) — Long Term Capital Lease Obligation: 841266000.00
PGEL.NS balance_sheet (quarterly, 2025-09-30) — Long Term Debt: 1725360000.00
PGEL.NS balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 2566626000.00
PGEL.NS balance_sheet (quarterly, 2025-09-30) — Long Term Provisions: 132826000.00
PGEL.NS income_statement (quarterly, 2025-09-30) — Minority Interests: 0.00
PGEL.NS balance_sheet (quarterly, 2025-09-30) — Net Debt: 4383511000.00
PGEL.NS income_statement (quarterly, 2025-09-30) — Net Income: 27598000.00
PGEL.NS income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: 27598000.00
PGEL.NS income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: 27597000.00
PGEL.NS income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: 27598000.00
PGEL.NS income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: 27598000.00
PGEL.NS income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: 27597000.00
PGEL.NS income_statement (quarterly, 2025-09-30) — Net Interest Income: -167129000.00
PGEL.NS income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: -167129000.00
PGEL.NS balance_sheet (quarterly, 2025-09-30) — Net PPE: 14310931000.00
PGEL.NS balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 28950488000.00
PGEL.NS balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Liabilities: 362417000.00
PGEL.NS income_statement (quarterly, 2025-09-30) — Normalized EBITDA: 446803000.00
PGEL.NS income_statement (quarterly, 2025-09-30) — Normalized Income: 27598000.00
PGEL.NS income_statement (quarterly, 2025-09-30) — Operating Income: 84490000.00
PGEL.NS income_statement (quarterly, 2025-09-30) — Operating Revenue: 6553661000.00
PGEL.NS balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 284075624.00
PGEL.NS balance_sheet (quarterly, 2025-09-30) — Other Current Assets: 2632287000.00
PGEL.NS balance_sheet (quarterly, 2025-09-30) — Other Current Liabilities: 1713635000.00
PGEL.NS balance_sheet (quarterly, 2025-09-30) — Other Equity Interest: 28737301000.00
PGEL.NS balance_sheet (quarterly, 2025-09-30) — Other Intangible Assets: 70855000.00
PGEL.NS balance_sheet (quarterly, 2025-09-30) — Other Non Current Assets: 2495896000.00
PGEL.NS balance_sheet (quarterly, 2025-09-30) — Other Non Current Liabilities: 265987000.00
PGEL.NS income_statement (quarterly, 2025-09-30) — Other Non Operating Income Expenses: 145854000.00
PGEL.NS income_statement (quarterly, 2025-09-30) — Other Operating Expenses: 563967000.00
PGEL.NS balance_sheet (quarterly, 2025-09-30) — Other Properties: 12065576000.00
PGEL.NS balance_sheet (quarterly, 2025-09-30) — Other Receivables: 152605000.00
PGEL.NS balance_sheet (quarterly, 2025-09-30) — Other Short Term Investments: 6227879000.00
PGEL.NS income_statement (quarterly, 2025-09-30) — Otherunder Preferred Stock Dividend: 0.00
PGEL.NS balance_sheet (quarterly, 2025-09-30) — Payables: 7906628000.00
PGEL.NS income_statement (quarterly, 2025-09-30) — Pretax Income: 63216000.00
PGEL.NS income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 5135674000.00
PGEL.NS income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 216458000.00
PGEL.NS balance_sheet (quarterly, 2025-09-30) — Share Issued: 284075658.00
PGEL.NS balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 29021377000.00
PGEL.NS balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 28950488000.00
PGEL.NS income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 0.00
PGEL.NS income_statement (quarterly, 2025-09-30) — Tax Provision: 39438000.00
PGEL.NS income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.30
PGEL.NS balance_sheet (quarterly, 2025-09-30) — Taxes Receivable: 208896000.00
PGEL.NS balance_sheet (quarterly, 2025-09-30) — Total Assets: 46651364000.00
PGEL.NS balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 30746737000.00
PGEL.NS balance_sheet (quarterly, 2025-09-30) — Total Debt: 5904654000.00
PGEL.NS balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 29021377000.00
PGEL.NS income_statement (quarterly, 2025-09-30) — Total Expenses: 6469171000.00
PGEL.NS balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 17629987000.00
PGEL.NS balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 17207541000.00
PGEL.NS balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 3343050000.00
PGEL.NS balance_sheet (quarterly, 2025-09-30) — Total Tax Payable: 97843000.00
PGEL.NS balance_sheet (quarterly, 2025-09-30) — Treasury Shares Number: 34.00
PGEL.NS balance_sheet (quarterly, 2025-09-30) — Working Capital: 15156886000.00
PGEL.NS income_statement (quarterly, 2025-12-31) — +Operating Expense: 1614403000.00
PGEL.NS income_statement (quarterly, 2025-12-31) — +Total Revenue: 14121302000.00
PGEL.NS income_statement (quarterly, 2025-12-31) — Basic Average Shares: 284214679.00
PGEL.NS income_statement (quarterly, 2025-12-31) — Basic EPS: 2.18
PGEL.NS income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 11557864000.00
PGEL.NS income_statement (quarterly, 2025-12-31) — Depreciation And Amortization In Income Statement: 219785000.00
PGEL.NS income_statement (quarterly, 2025-12-31) — Depreciation Income Statement: 219785000.00
PGEL.NS income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 289527103.00
PGEL.NS income_statement (quarterly, 2025-12-31) — Diluted EPS: 2.14
PGEL.NS income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: 619588000.00
PGEL.NS income_statement (quarterly, 2025-12-31) — EBIT: 1041351000.00
PGEL.NS income_statement (quarterly, 2025-12-31) — EBITDA: 1261136000.00
PGEL.NS income_statement (quarterly, 2025-12-31) — Gross Profit: 2563438000.00
PGEL.NS income_statement (quarterly, 2025-12-31) — Interest Expense: 250183000.00
PGEL.NS income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 250183000.00
PGEL.NS income_statement (quarterly, 2025-12-31) — Minority Interests: 0.00
PGEL.NS income_statement (quarterly, 2025-12-31) — Net Income: 619588000.00
PGEL.NS income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: 619588000.00
PGEL.NS income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: 619588000.00
PGEL.NS income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 619588000.00
PGEL.NS income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 619588000.00
PGEL.NS income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: 619588000.00
PGEL.NS income_statement (quarterly, 2025-12-31) — Net Interest Income: -250183000.00
PGEL.NS income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: -250183000.00
PGEL.NS income_statement (quarterly, 2025-12-31) — Normalized EBITDA: 1261136000.00
PGEL.NS income_statement (quarterly, 2025-12-31) — Normalized Income: 619588000.00
PGEL.NS income_statement (quarterly, 2025-12-31) — Operating Income: 949035000.00
PGEL.NS income_statement (quarterly, 2025-12-31) — Operating Revenue: 14121302000.00
PGEL.NS income_statement (quarterly, 2025-12-31) — Other Non Operating Income Expenses: 92316000.00
PGEL.NS income_statement (quarterly, 2025-12-31) — Other Operating Expenses: 609616000.00
PGEL.NS income_statement (quarterly, 2025-12-31) — Otherunder Preferred Stock Dividend: 0.00
PGEL.NS income_statement (quarterly, 2025-12-31) — Pretax Income: 791168000.00
PGEL.NS income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 11557864000.00
PGEL.NS income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 219785000.00
PGEL.NS income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
PGEL.NS income_statement (quarterly, 2025-12-31) — Tax Provision: 188046000.00
PGEL.NS income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.24
PGEL.NS income_statement (quarterly, 2025-12-31) — Total Expenses: 13172267000.00
PGEL.NS income_statement (annual, 2026-03-31) — +Operating Expense: 6339425000.00
PGEL.NS income_statement (quarterly, 2026-03-31) — +Operating Expense: 1744560000.00
PGEL.NS income_statement (annual, 2026-03-31) — +Total Revenue: 52880219000.00
PGEL.NS income_statement (quarterly, 2026-03-31) — +Total Revenue: 17166752000.00
PGEL.NS balance_sheet (annual, 2026-03-31) — Accounts Payable: 17573206000.00
PGEL.NS balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 17573206000.00
PGEL.NS balance_sheet (annual, 2026-03-31) — Accounts Receivable: 11839638000.00
PGEL.NS balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 11839638000.00
PGEL.NS balance_sheet (annual, 2026-03-31) — Available For Sale Securities: 454766000.00
PGEL.NS balance_sheet (quarterly, 2026-03-31) — Available For Sale Securities: 454766000.00
PGEL.NS income_statement (annual, 2026-03-31) — Basic Average Shares: 284467294.00
PGEL.NS income_statement (quarterly, 2026-03-31) — Basic Average Shares: 285743612.00
PGEL.NS income_statement (annual, 2026-03-31) — Basic EPS: 6.91
PGEL.NS income_statement (quarterly, 2026-03-31) — Basic EPS: 2.27
PGEL.NS cash_flow (annual, 2026-03-31) — Beginning Cash Position: 812170000.00
PGEL.NS cash_flow (annual, 2026-03-31) — Capital Expenditure: -7848619000.00
PGEL.NS balance_sheet (annual, 2026-03-31) — Capital Lease Obligations: 968177000.00
PGEL.NS balance_sheet (quarterly, 2026-03-31) — Capital Lease Obligations: 968177000.00
PGEL.NS balance_sheet (annual, 2026-03-31) — Capital Stock: 285343000.00
PGEL.NS balance_sheet (quarterly, 2026-03-31) — Capital Stock: 285343000.00
PGEL.NS balance_sheet (annual, 2026-03-31) — Cash And Cash Equivalents: 315557000.00
PGEL.NS balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 315557000.00
PGEL.NS balance_sheet (annual, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 5566310000.00
PGEL.NS balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 5566310000.00
PGEL.NS cash_flow (annual, 2026-03-31) — Cash Dividends Paid: -71019000.00
PGEL.NS cash_flow (annual, 2026-03-31) — Change In Inventory: -2851185000.00
PGEL.NS cash_flow (annual, 2026-03-31) — Change In Other Current Assets: -1551123000.00
PGEL.NS cash_flow (annual, 2026-03-31) — Change In Other Current Liabilities: -152834000.00
PGEL.NS cash_flow (annual, 2026-03-31) — Change In Payable: 3830155000.00
PGEL.NS cash_flow (annual, 2026-03-31) — Change In Receivables: -1997528000.00
PGEL.NS cash_flow (annual, 2026-03-31) — Change In Working Capital: -2707767000.00
PGEL.NS cash_flow (annual, 2026-03-31) — Changes In Cash: -496613000.00
PGEL.NS balance_sheet (annual, 2026-03-31) — Common Stock: 285343000.00
PGEL.NS balance_sheet (quarterly, 2026-03-31) — Common Stock: 285343000.00
PGEL.NS balance_sheet (annual, 2026-03-31) — Common Stock Equity: 30485868000.00
PGEL.NS balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 30485868000.00
PGEL.NS cash_flow (annual, 2026-03-31) — Common Stock Issuance: 167068000.00
PGEL.NS balance_sheet (annual, 2026-03-31) — Construction In Progress: 3124367000.00
PGEL.NS balance_sheet (quarterly, 2026-03-31) — Construction In Progress: 3124367000.00
PGEL.NS income_statement (annual, 2026-03-31) — Cost Of Revenue: 43552847000.00
PGEL.NS income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 14471822000.00
PGEL.NS balance_sheet (annual, 2026-03-31) — Current Assets: 37939385000.00
PGEL.NS balance_sheet (quarterly, 2026-03-31) — Current Assets: 37939385000.00
PGEL.NS balance_sheet (annual, 2026-03-31) — Current Capital Lease Obligation: 237249000.00
PGEL.NS balance_sheet (quarterly, 2026-03-31) — Current Capital Lease Obligation: 237249000.00
PGEL.NS balance_sheet (annual, 2026-03-31) — Current Debt: 3616959000.00
PGEL.NS balance_sheet (quarterly, 2026-03-31) — Current Debt: 3616959000.00
PGEL.NS balance_sheet (annual, 2026-03-31) — Current Debt And Capital Lease Obligation: 3854208000.00
PGEL.NS balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 3854208000.00
PGEL.NS balance_sheet (annual, 2026-03-31) — Current Liabilities: 25944792000.00
PGEL.NS balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 25944792000.00
PGEL.NS balance_sheet (annual, 2026-03-31) — Current Provisions: 42126000.00
PGEL.NS balance_sheet (quarterly, 2026-03-31) — Current Provisions: 42126000.00
PGEL.NS cash_flow (annual, 2026-03-31) — Depreciation: 881732000.00
PGEL.NS cash_flow (annual, 2026-03-31) — Depreciation And Amortization: 881732000.00
PGEL.NS income_statement (annual, 2026-03-31) — Depreciation And Amortization In Income Statement: 881732000.00
PGEL.NS income_statement (quarterly, 2026-03-31) — Depreciation And Amortization In Income Statement: 237166000.00
PGEL.NS income_statement (annual, 2026-03-31) — Depreciation Income Statement: 881732000.00
PGEL.NS income_statement (quarterly, 2026-03-31) — Depreciation Income Statement: 237166000.00
PGEL.NS income_statement (annual, 2026-03-31) — Diluted Average Shares: 284467294.00
PGEL.NS income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 285743612.00
PGEL.NS income_statement (annual, 2026-03-31) — Diluted EPS: 6.91
PGEL.NS income_statement (quarterly, 2026-03-31) — Diluted EPS: 2.27
PGEL.NS income_statement (annual, 2026-03-31) — Diluted NI Availto Com Stockholders: 1965669000.00
PGEL.NS income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: 648638000.00
PGEL.NS income_statement (annual, 2026-03-31) — EBIT: 3535828000.00
PGEL.NS income_statement (quarterly, 2026-03-31) — EBIT: 1078266000.00
PGEL.NS income_statement (annual, 2026-03-31) — EBITDA: 4417560000.00
PGEL.NS income_statement (quarterly, 2026-03-31) — EBITDA: 1315432000.00
PGEL.NS cash_flow (annual, 2026-03-31) — End Cash Position: 315557000.00
PGEL.NS cash_flow (annual, 2026-03-31) — Financing Cash Flow: 817752000.00
PGEL.NS cash_flow (annual, 2026-03-31) — Free Cash Flow: -7186461000.00
PGEL.NS cash_flow (annual, 2026-03-31) — Gain Loss On Investment Securities: 417000.00
PGEL.NS cash_flow (annual, 2026-03-31) — Gain Loss On Sale Of PPE: 2994000.00
PGEL.NS balance_sheet (annual, 2026-03-31) — Goodwill: 34000.00
PGEL.NS balance_sheet (quarterly, 2026-03-31) — Goodwill: 34000.00
PGEL.NS balance_sheet (annual, 2026-03-31) — Goodwill And Other Intangible Assets: 52143000.00
PGEL.NS balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 52143000.00
PGEL.NS balance_sheet (annual, 2026-03-31) — Gross PPE: 18472502000.00
PGEL.NS balance_sheet (quarterly, 2026-03-31) — Gross PPE: 18472502000.00
PGEL.NS income_statement (annual, 2026-03-31) — Gross Profit: 9327372000.00
PGEL.NS income_statement (quarterly, 2026-03-31) — Gross Profit: 2694930000.00
PGEL.NS income_statement (annual, 2026-03-31) — Interest Expense: 1016450000.00
PGEL.NS income_statement (quarterly, 2026-03-31) — Interest Expense: 260100000.00
PGEL.NS income_statement (annual, 2026-03-31) — Interest Expense Non Operating: 1016450000.00
PGEL.NS income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 260100000.00
PGEL.NS cash_flow (annual, 2026-03-31) — Interest Paid Cff: -1014239000.00
PGEL.NS cash_flow (annual, 2026-03-31) — Interest Received Cfi: 559517000.00
PGEL.NS balance_sheet (annual, 2026-03-31) — Inventory: 16013059000.00
PGEL.NS balance_sheet (quarterly, 2026-03-31) — Inventory: 16013059000.00
PGEL.NS balance_sheet (annual, 2026-03-31) — Invested Capital: 35482973000.00
PGEL.NS balance_sheet (quarterly, 2026-03-31) — Invested Capital: 35482973000.00
PGEL.NS cash_flow (annual, 2026-03-31) — Investing Cash Flow: -1976523000.00
PGEL.NS balance_sheet (annual, 2026-03-31) — Investmentin Financial Assets: 454766000.00
PGEL.NS balance_sheet (quarterly, 2026-03-31) — Investmentin Financial Assets: 454766000.00
PGEL.NS cash_flow (annual, 2026-03-31) — Issuance Of Capital Stock: 167068000.00
PGEL.NS cash_flow (annual, 2026-03-31) — Issuance Of Debt: 1496536000.00
PGEL.NS balance_sheet (annual, 2026-03-31) — Long Term Capital Lease Obligation: 730928000.00
PGEL.NS balance_sheet (quarterly, 2026-03-31) — Long Term Capital Lease Obligation: 730928000.00
PGEL.NS balance_sheet (annual, 2026-03-31) — Long Term Debt: 1380146000.00
PGEL.NS balance_sheet (quarterly, 2026-03-31) — Long Term Debt: 1380146000.00
PGEL.NS balance_sheet (annual, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 2111074000.00
PGEL.NS balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 2111074000.00
PGEL.NS cash_flow (annual, 2026-03-31) — Long Term Debt Issuance: 1496536000.00
PGEL.NS cash_flow (annual, 2026-03-31) — Long Term Debt Payments: -1922771000.00
PGEL.NS balance_sheet (annual, 2026-03-31) — Long Term Provisions: 119435000.00
PGEL.NS balance_sheet (quarterly, 2026-03-31) — Long Term Provisions: 119435000.00
PGEL.NS cash_flow (annual, 2026-03-31) — Net Common Stock Issuance: 167068000.00
PGEL.NS balance_sheet (annual, 2026-03-31) — Net Debt: 4681548000.00
PGEL.NS balance_sheet (quarterly, 2026-03-31) — Net Debt: 4681548000.00
PGEL.NS income_statement (annual, 2026-03-31) — Net Income: 1965669000.00
PGEL.NS income_statement (quarterly, 2026-03-31) — Net Income: 648638000.00
PGEL.NS income_statement (annual, 2026-03-31) — Net Income Common Stockholders: 1965669000.00
PGEL.NS income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: 648638000.00
PGEL.NS income_statement (annual, 2026-03-31) — Net Income Continuous Operations: 1965669000.00
PGEL.NS income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: 648638000.00
PGEL.NS income_statement (annual, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 1965669000.00
PGEL.NS income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 648638000.00
PGEL.NS income_statement (annual, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 1965669000.00
PGEL.NS income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 648638000.00
PGEL.NS cash_flow (annual, 2026-03-31) — Net Income From Continuing Operations: 2519378000.00
PGEL.NS income_statement (annual, 2026-03-31) — Net Income Including Noncontrolling Interests: 1965669000.00
PGEL.NS income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: 648638000.00
PGEL.NS income_statement (annual, 2026-03-31) — Net Interest Income: -1016450000.00
PGEL.NS income_statement (quarterly, 2026-03-31) — Net Interest Income: -260100000.00
PGEL.NS cash_flow (annual, 2026-03-31) — Net Investment Purchase And Sale: 5295555000.00
PGEL.NS cash_flow (annual, 2026-03-31) — Net Issuance Payments Of Debt: 1977523000.00
PGEL.NS cash_flow (annual, 2026-03-31) — Net Long Term Debt Issuance: -426235000.00
PGEL.NS income_statement (annual, 2026-03-31) — Net Non Operating Interest Income Expense: -1016450000.00
PGEL.NS income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: -260100000.00
PGEL.NS balance_sheet (annual, 2026-03-31) — Net PPE: 18472502000.00
PGEL.NS balance_sheet (quarterly, 2026-03-31) — Net PPE: 18472502000.00
PGEL.NS cash_flow (annual, 2026-03-31) — Net PPE Purchase And Sale: -7831595000.00
PGEL.NS cash_flow (annual, 2026-03-31) — Net Short Term Debt Issuance: 2403758000.00
PGEL.NS balance_sheet (annual, 2026-03-31) — Net Tangible Assets: 30433725000.00
PGEL.NS balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 30433725000.00
PGEL.NS balance_sheet (annual, 2026-03-31) — Non Current Deferred Taxes Liabilities: 446998000.00
PGEL.NS balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Liabilities: 446998000.00
PGEL.NS income_statement (annual, 2026-03-31) — Normalized EBITDA: 4417560000.00
PGEL.NS income_statement (quarterly, 2026-03-31) — Normalized EBITDA: 1315432000.00
PGEL.NS income_statement (annual, 2026-03-31) — Normalized Income: 1965669000.00
PGEL.NS income_statement (quarterly, 2026-03-31) — Normalized Income: 648638000.00
PGEL.NS cash_flow (annual, 2026-03-31) — Operating Cash Flow: 662158000.00
PGEL.NS income_statement (annual, 2026-03-31) — Operating Income: 2987947000.00
PGEL.NS income_statement (quarterly, 2026-03-31) — Operating Income: 950370000.00
PGEL.NS income_statement (annual, 2026-03-31) — Operating Revenue: 52880219000.00
PGEL.NS income_statement (quarterly, 2026-03-31) — Operating Revenue: 17166752000.00
PGEL.NS balance_sheet (annual, 2026-03-31) — Ordinary Shares Number: 285326508.00
PGEL.NS balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 285326508.00
PGEL.NS balance_sheet (annual, 2026-03-31) — Other Current Assets: 4494182000.00
PGEL.NS balance_sheet (quarterly, 2026-03-31) — Other Current Assets: 4494182000.00
PGEL.NS balance_sheet (annual, 2026-03-31) — Other Current Liabilities: 2278701000.00
PGEL.NS balance_sheet (quarterly, 2026-03-31) — Other Current Liabilities: 2278701000.00
PGEL.NS balance_sheet (annual, 2026-03-31) — Other Equity Interest: 30200525000.00
PGEL.NS balance_sheet (quarterly, 2026-03-31) — Other Equity Interest: 30200525000.00
PGEL.NS balance_sheet (annual, 2026-03-31) — Other Intangible Assets: 52109000.00
PGEL.NS balance_sheet (quarterly, 2026-03-31) — Other Intangible Assets: 52109000.00
PGEL.NS cash_flow (annual, 2026-03-31) — Other Non Cash Items: 511247000.00
PGEL.NS balance_sheet (annual, 2026-03-31) — Other Non Current Assets: 2311304000.00
PGEL.NS balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 2311304000.00
PGEL.NS balance_sheet (annual, 2026-03-31) — Other Non Current Liabilities: 346457000.00
PGEL.NS balance_sheet (quarterly, 2026-03-31) — Other Non Current Liabilities: 346457000.00
PGEL.NS income_statement (annual, 2026-03-31) — Other Non Operating Income Expenses: 547881000.00
PGEL.NS income_statement (quarterly, 2026-03-31) — Other Non Operating Income Expenses: 127896000.00
PGEL.NS income_statement (annual, 2026-03-31) — Other Operating Expenses: 2486110000.00
PGEL.NS income_statement (quarterly, 2026-03-31) — Other Operating Expenses: 660249000.00
PGEL.NS balance_sheet (annual, 2026-03-31) — Other Properties: 15348135000.00
PGEL.NS balance_sheet (quarterly, 2026-03-31) — Other Properties: 15348135000.00
PGEL.NS balance_sheet (annual, 2026-03-31) — Other Receivables: 26196000.00
PGEL.NS balance_sheet (quarterly, 2026-03-31) — Other Receivables: 26196000.00
PGEL.NS balance_sheet (annual, 2026-03-31) — Other Short Term Investments: 5250753000.00
PGEL.NS balance_sheet (quarterly, 2026-03-31) — Other Short Term Investments: 5250753000.00
PGEL.NS income_statement (annual, 2026-03-31) — Otherunder Preferred Stock Dividend: 0.00
PGEL.NS income_statement (quarterly, 2026-03-31) — Otherunder Preferred Stock Dividend: 0.00
PGEL.NS balance_sheet (annual, 2026-03-31) — Payables: 17597655000.00
PGEL.NS balance_sheet (quarterly, 2026-03-31) — Payables: 17597655000.00
PGEL.NS cash_flow (annual, 2026-03-31) — Pension And Employee Benefit Expense: 18086000.00
PGEL.NS income_statement (annual, 2026-03-31) — Pretax Income: 2519378000.00
PGEL.NS income_statement (quarterly, 2026-03-31) — Pretax Income: 818166000.00
PGEL.NS cash_flow (annual, 2026-03-31) — Provisionand Write Offof Assets: 28623000.00
PGEL.NS cash_flow (annual, 2026-03-31) — Purchase Of PPE: -7848619000.00
PGEL.NS income_statement (annual, 2026-03-31) — Reconciled Cost Of Revenue: 43552847000.00
PGEL.NS income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 14471822000.00
PGEL.NS income_statement (annual, 2026-03-31) — Reconciled Depreciation: 881732000.00
PGEL.NS income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 237166000.00
PGEL.NS cash_flow (annual, 2026-03-31) — Repayment Of Debt: -1922771000.00
PGEL.NS cash_flow (annual, 2026-03-31) — Sale Of Investment: 5295555000.00
PGEL.NS cash_flow (annual, 2026-03-31) — Sale Of PPE: 17024000.00
PGEL.NS balance_sheet (annual, 2026-03-31) — Share Issued: 285342658.00
PGEL.NS balance_sheet (quarterly, 2026-03-31) — Share Issued: 285342658.00
PGEL.NS cash_flow (annual, 2026-03-31) — Stock Based Compensation: 123103000.00
PGEL.NS balance_sheet (annual, 2026-03-31) — Stockholders Equity: 30485868000.00
PGEL.NS balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 30485868000.00
PGEL.NS balance_sheet (annual, 2026-03-31) — Tangible Book Value: 30433725000.00
PGEL.NS balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 30433725000.00
PGEL.NS income_statement (annual, 2026-03-31) — Tax Effect Of Unusual Items: 0.00
PGEL.NS income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: 0.00
PGEL.NS income_statement (annual, 2026-03-31) — Tax Provision: 583361000.00
PGEL.NS income_statement (quarterly, 2026-03-31) — Tax Provision: 176166000.00
PGEL.NS income_statement (annual, 2026-03-31) — Tax Rate For Calcs: 0.23
PGEL.NS income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.22
PGEL.NS cash_flow (annual, 2026-03-31) — Taxes Refund Paid: -721952000.00
PGEL.NS balance_sheet (annual, 2026-03-31) — Total Assets: 59466750000.00
PGEL.NS balance_sheet (quarterly, 2026-03-31) — Total Assets: 59466750000.00
PGEL.NS balance_sheet (annual, 2026-03-31) — Total Capitalization: 31866014000.00
PGEL.NS balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 31866014000.00
PGEL.NS balance_sheet (annual, 2026-03-31) — Total Debt: 5965282000.00
PGEL.NS balance_sheet (quarterly, 2026-03-31) — Total Debt: 5965282000.00
PGEL.NS balance_sheet (annual, 2026-03-31) — Total Equity Gross Minority Interest: 30485868000.00
PGEL.NS balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 30485868000.00
PGEL.NS income_statement (annual, 2026-03-31) — Total Expenses: 49892272000.00
PGEL.NS income_statement (quarterly, 2026-03-31) — Total Expenses: 16216382000.00
PGEL.NS balance_sheet (annual, 2026-03-31) — Total Liabilities Net Minority Interest: 28980882000.00
PGEL.NS balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 28980882000.00
PGEL.NS balance_sheet (annual, 2026-03-31) — Total Non Current Assets: 21527365000.00
PGEL.NS balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 21527365000.00
PGEL.NS balance_sheet (annual, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 3036090000.00
PGEL.NS balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 3036090000.00
PGEL.NS balance_sheet (annual, 2026-03-31) — Total Tax Payable: 24449000.00
PGEL.NS balance_sheet (quarterly, 2026-03-31) — Total Tax Payable: 24449000.00
PGEL.NS balance_sheet (annual, 2026-03-31) — Treasury Shares Number: 16150.00
PGEL.NS balance_sheet (quarterly, 2026-03-31) — Treasury Shares Number: 16150.00
PGEL.NS balance_sheet (annual, 2026-03-31) — Working Capital: 11994593000.00
PGEL.NS balance_sheet (quarterly, 2026-03-31) — Working Capital: 11994593000.00
PGEN balance_sheet (annual, 2021-12-31) — Assets Held For Sale Current: 40188000.00
PGEN balance_sheet (annual, 2021-12-31) — Available For Sale Securities: 48562000.00
PGEN cash_flow (annual, 2021-12-31) — Cash From Discontinued Investing Activities: 0.00
PGEN cash_flow (annual, 2021-12-31) — Common Stock Issuance: 121045000.00
PGEN balance_sheet (annual, 2021-12-31) — Current Debt: 52000.00
PGEN balance_sheet (annual, 2021-12-31) — Duefrom Related Parties Current: 73000.00
PGEN balance_sheet (annual, 2021-12-31) — Dueto Related Parties Current: 74000.00
PGEN income_statement (annual, 2021-12-31) — Earnings From Equity Interest: -3000.00
PGEN cash_flow (annual, 2021-12-31) — Earnings Losses From Equity Investments: 3000.00
PGEN balance_sheet (annual, 2021-12-31) — Finished Goods: 8109000.00
PGEN balance_sheet (annual, 2021-12-31) — Inventory: 326000.00
PGEN balance_sheet (annual, 2021-12-31) — Investmentin Financial Assets: 48562000.00
PGEN balance_sheet (annual, 2021-12-31) — Investments And Advances: 48562000.00
PGEN cash_flow (annual, 2021-12-31) — Issuance Of Capital Stock: 121045000.00
PGEN balance_sheet (annual, 2021-12-31) — Liabilities Heldfor Sale Non Current: 3672000.00
PGEN balance_sheet (annual, 2021-12-31) — Long Term Debt: 179882000.00
PGEN cash_flow (annual, 2021-12-31) — Long Term Debt Issuance: 0.00
PGEN income_statement (annual, 2021-12-31) — Minority Interests: 0.00
PGEN cash_flow (annual, 2021-12-31) — Net Business Purchase And Sale: 0.00
PGEN balance_sheet (annual, 2021-12-31) — Net Debt: 143511000.00
PGEN income_statement (annual, 2021-12-31) — Net Income Discontinuous Operations: 18641000.00
PGEN cash_flow (annual, 2021-12-31) — Net Other Investing Changes: 6760000.00
PGEN cash_flow (annual, 2021-12-31) — Net Short Term Debt Issuance: 0.00
PGEN balance_sheet (annual, 2021-12-31) — Non Current Deferred Taxes Liabilities: 2539000.00
PGEN balance_sheet (annual, 2021-12-31) — Notes Receivable: 0.00
PGEN balance_sheet (annual, 2021-12-31) — Other Current Borrowings: 52000.00
PGEN balance_sheet (annual, 2021-12-31) — Other Current Liabilities: 12851000.00
PGEN balance_sheet (annual, 2021-12-31) — Other Inventories: 303000.00
PGEN balance_sheet (annual, 2021-12-31) — Other Non Current Liabilities: 50000.00
PGEN balance_sheet (annual, 2021-12-31) — Prepaid Assets: 6736000.00
PGEN cash_flow (annual, 2021-12-31) — Provisionand Write Offof Assets: 1268000.00
PGEN cash_flow (annual, 2021-12-31) — Purchase Of Business: 0.00
PGEN balance_sheet (annual, 2021-12-31) — Raw Materials: 23000.00
PGEN balance_sheet (annual, 2021-12-31) — Restricted Cash: 0.00
PGEN income_statement (annual, 2021-12-31) — Restructuring And Mergern Acquisition: 0.00
PGEN cash_flow (annual, 2021-12-31) — Sale Of Business: 0.00
PGEN cash_flow (annual, 2021-12-31) — Short Term Debt Issuance: 0.00
PGEN cash_flow (annual, 2021-12-31) — Short Term Debt Payments: 0.00
PGEN cash_flow (annual, 2021-12-31) — Unrealized Gain Loss On Investment Securities: 0.00
PGEN balance_sheet (annual, 2021-12-31) — Work In Process: 2564000.00
PGEN income_statement (annual, 2021-12-31) — Write Off: 543000.00
PGEN income_statement (annual, 2022-12-31) — +Operating Expense: 95176000.00
PGEN income_statement (annual, 2022-12-31) — +Total Revenue: 26909000.00
PGEN balance_sheet (annual, 2022-12-31) — Accounts Payable: 4068000.00
PGEN balance_sheet (annual, 2022-12-31) — Accounts Receivable: 978000.00
PGEN balance_sheet (annual, 2022-12-31) — Accumulated Depreciation: -23439000.00
PGEN balance_sheet (annual, 2022-12-31) — Additional Paid In Capital: 1998314000.00
PGEN balance_sheet (annual, 2022-12-31) — Allowance For Doubtful Accounts Receivable: -184000.00
PGEN cash_flow (annual, 2022-12-31) — Amortization Of Securities: 832000.00
PGEN cash_flow (annual, 2022-12-31) — Asset Impairment Charge: 1120000.00
PGEN balance_sheet (annual, 2022-12-31) — Assets Held For Sale Current: 0.00
PGEN income_statement (annual, 2022-12-31) — Basic Average Shares: 200360821.00
PGEN income_statement (annual, 2022-12-31) — Basic EPS: 0.14
PGEN cash_flow (annual, 2022-12-31) — Beginning Cash Position: 43343000.00
PGEN balance_sheet (annual, 2022-12-31) — Buildings And Improvements: 2592000.00
PGEN cash_flow (annual, 2022-12-31) — Capital Expenditure: -4924000.00
PGEN balance_sheet (annual, 2022-12-31) — Capital Lease Obligations: 8201000.00
PGEN balance_sheet (annual, 2022-12-31) — Capital Stock: 0.00
PGEN balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 4858000.00
PGEN balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Short Term Investments: 55950000.00
PGEN cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Financing Activities: -155292000.00
PGEN cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Investing Activities: 64111000.00
PGEN cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Operating Activities: -65045000.00
PGEN cash_flow (annual, 2022-12-31) — Cash From Discontinued Investing Activities: 162306000.00
PGEN cash_flow (annual, 2022-12-31) — Change In Account Payable: 379000.00
PGEN cash_flow (annual, 2022-12-31) — Change In Accrued Expense: -1517000.00
PGEN cash_flow (annual, 2022-12-31) — Change In Inventory: 2341000.00
PGEN cash_flow (annual, 2022-12-31) — Change In Other Current Assets: -101000.00
PGEN cash_flow (annual, 2022-12-31) — Change In Other Current Liabilities: -144000.00
PGEN cash_flow (annual, 2022-12-31) — Change In Other Working Capital: -23433000.00
PGEN cash_flow (annual, 2022-12-31) — Change In Payable: 379000.00
PGEN cash_flow (annual, 2022-12-31) — Change In Payables And Accrued Expense: -1138000.00
PGEN cash_flow (annual, 2022-12-31) — Change In Prepaid Assets: 2630000.00
PGEN cash_flow (annual, 2022-12-31) — Change In Receivables: -13513000.00
PGEN cash_flow (annual, 2022-12-31) — Change In Working Capital: -35699000.00
PGEN cash_flow (annual, 2022-12-31) — Changes In Account Receivables: -2175000.00
PGEN cash_flow (annual, 2022-12-31) — Changes In Cash: 6080000.00
PGEN balance_sheet (annual, 2022-12-31) — Common Stock: 0.00
PGEN balance_sheet (annual, 2022-12-31) — Common Stock Equity: 126259000.00
PGEN cash_flow (annual, 2022-12-31) — Common Stock Issuance: 0.00
PGEN balance_sheet (annual, 2022-12-31) — Construction In Progress: 531000.00
PGEN income_statement (annual, 2022-12-31) — Cost Of Revenue: 6339000.00
PGEN balance_sheet (annual, 2022-12-31) — Current Accrued Expenses: 23747000.00
PGEN balance_sheet (annual, 2022-12-31) — Current Assets: 118159000.00
PGEN balance_sheet (annual, 2022-12-31) — Current Capital Lease Obligation: 1209000.00
PGEN balance_sheet (annual, 2022-12-31) — Current Debt: 43219000.00
PGEN balance_sheet (annual, 2022-12-31) — Current Debt And Capital Lease Obligation: 44428000.00
PGEN balance_sheet (annual, 2022-12-31) — Current Deferred Liabilities: 25000.00
PGEN balance_sheet (annual, 2022-12-31) — Current Deferred Revenue: 25000.00
PGEN balance_sheet (annual, 2022-12-31) — Current Liabilities: 78645000.00
PGEN cash_flow (annual, 2022-12-31) — Deferred Income Tax: -150000.00
PGEN cash_flow (annual, 2022-12-31) — Deferred Tax: -150000.00
PGEN cash_flow (annual, 2022-12-31) — Depreciation Amortization Depletion: 10765000.00
PGEN cash_flow (annual, 2022-12-31) — Depreciation And Amortization: 10765000.00
PGEN income_statement (annual, 2022-12-31) — Diluted Average Shares: 200360821.00
PGEN income_statement (annual, 2022-12-31) — Diluted EPS: 0.14
PGEN income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: 28317000.00
PGEN balance_sheet (annual, 2022-12-31) — Duefrom Related Parties Current: 19000.00
PGEN balance_sheet (annual, 2022-12-31) — Dueto Related Parties Current: 0.00
PGEN income_statement (annual, 2022-12-31) — EBIT: -73192000.00
PGEN income_statement (annual, 2022-12-31) — EBITDA: -62427000.00
PGEN income_statement (annual, 2022-12-31) — Earnings From Equity Interest: 862000.00
PGEN cash_flow (annual, 2022-12-31) — Earnings Losses From Equity Investments: -862000.00
PGEN cash_flow (annual, 2022-12-31) — Effect Of Exchange Rate Changes: -827000.00
PGEN cash_flow (annual, 2022-12-31) — End Cash Position: 48596000.00
PGEN cash_flow (annual, 2022-12-31) — Financing Cash Flow: -155292000.00
PGEN cash_flow (annual, 2022-12-31) — Free Cash Flow: -69969000.00
PGEN balance_sheet (annual, 2022-12-31) — Gains Losses Not Affecting Retained Earnings: -3488000.00
PGEN balance_sheet (annual, 2022-12-31) — Goodwill: 36923000.00
PGEN balance_sheet (annual, 2022-12-31) — Goodwill And Other Intangible Assets: 81378000.00
PGEN balance_sheet (annual, 2022-12-31) — Gross Accounts Receivable: 1162000.00
PGEN balance_sheet (annual, 2022-12-31) — Gross PPE: 38731000.00
PGEN income_statement (annual, 2022-12-31) — Gross Profit: 20570000.00
PGEN income_statement (annual, 2022-12-31) — Impairment Of Capital Assets: 1120000.00
PGEN cash_flow (annual, 2022-12-31) — Income Tax Paid Supplemental Data: 0.00
PGEN income_statement (annual, 2022-12-31) — Interest Expense: 6774000.00
PGEN income_statement (annual, 2022-12-31) — Interest Expense Non Operating: 6774000.00
PGEN income_statement (annual, 2022-12-31) — Interest Income: 133000.00
PGEN income_statement (annual, 2022-12-31) — Interest Income Non Operating: 133000.00
PGEN cash_flow (annual, 2022-12-31) — Interest Paid Supplemental Data: 8535000.00
PGEN balance_sheet (annual, 2022-12-31) — Inventory: 287000.00
PGEN balance_sheet (annual, 2022-12-31) — Invested Capital: 169478000.00
PGEN cash_flow (annual, 2022-12-31) — Investing Cash Flow: 226417000.00
PGEN balance_sheet (annual, 2022-12-31) — Investmentin Financial Assets: 0.00
PGEN balance_sheet (annual, 2022-12-31) — Investments And Advances: 0.00
PGEN cash_flow (annual, 2022-12-31) — Issuance Of Capital Stock: 0.00
PGEN cash_flow (annual, 2022-12-31) — Issuance Of Debt: 0.00
PGEN balance_sheet (annual, 2022-12-31) — Land And Improvements: 164000.00
PGEN balance_sheet (annual, 2022-12-31) — Leases: 4333000.00
PGEN balance_sheet (annual, 2022-12-31) — Liabilities Heldfor Sale Non Current: 0.00
PGEN balance_sheet (annual, 2022-12-31) — Long Term Capital Lease Obligation: 6992000.00
PGEN balance_sheet (annual, 2022-12-31) — Long Term Debt And Capital Lease Obligation: 6992000.00
PGEN cash_flow (annual, 2022-12-31) — Long Term Debt Payments: -155293000.00
PGEN balance_sheet (annual, 2022-12-31) — Machinery Furniture Equipment: 5019000.00
PGEN cash_flow (annual, 2022-12-31) — Net Common Stock Issuance: 0.00
PGEN balance_sheet (annual, 2022-12-31) — Net Debt: 38361000.00
PGEN cash_flow (annual, 2022-12-31) — Net Foreign Currency Exchange Gain Loss: 0.00
PGEN income_statement (annual, 2022-12-31) — Net Income: 28317000.00
PGEN income_statement (annual, 2022-12-31) — Net Income Common Stockholders: 28317000.00
PGEN income_statement (annual, 2022-12-31) — Net Income Continuous Operations: -79777000.00
PGEN income_statement (annual, 2022-12-31) — Net Income Discontinuous Operations: 108094000.00
PGEN income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: 28317000.00
PGEN income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: -79777000.00
PGEN cash_flow (annual, 2022-12-31) — Net Income From Continuing Operations: 28317000.00
PGEN income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: 28317000.00
PGEN income_statement (annual, 2022-12-31) — Net Interest Income: -6641000.00
PGEN cash_flow (annual, 2022-12-31) — Net Investment Purchase And Sale: 68441000.00
PGEN cash_flow (annual, 2022-12-31) — Net Issuance Payments Of Debt: -155293000.00
PGEN cash_flow (annual, 2022-12-31) — Net Long Term Debt Issuance: -155293000.00
PGEN income_statement (annual, 2022-12-31) — Net Non Operating Interest Income Expense: -6641000.00
PGEN cash_flow (annual, 2022-12-31) — Net Other Financing Charges: -588000.00
PGEN cash_flow (annual, 2022-12-31) — Net Other Investing Changes: 594000.00
PGEN balance_sheet (annual, 2022-12-31) — Net PPE: 15292000.00
PGEN cash_flow (annual, 2022-12-31) — Net PPE Purchase And Sale: -4924000.00
PGEN cash_flow (annual, 2022-12-31) — Net Preferred Stock Issuance: 0.00
PGEN cash_flow (annual, 2022-12-31) — Net Short Term Debt Issuance: 0.00
PGEN balance_sheet (annual, 2022-12-31) — Net Tangible Assets: 44881000.00
PGEN balance_sheet (annual, 2022-12-31) — Non Current Deferred Liabilities: 4081000.00
PGEN balance_sheet (annual, 2022-12-31) — Non Current Deferred Revenue: 1818000.00
PGEN balance_sheet (annual, 2022-12-31) — Non Current Deferred Taxes Liabilities: 2263000.00
PGEN income_statement (annual, 2022-12-31) — Normalized EBITDA: -61307000.00
PGEN income_statement (annual, 2022-12-31) — Normalized Income: -78659647.13
PGEN cash_flow (annual, 2022-12-31) — Operating Cash Flow: -65045000.00
PGEN cash_flow (annual, 2022-12-31) — Operating Gains Losses: -1402000.00
PGEN income_statement (annual, 2022-12-31) — Operating Income: -74606000.00
PGEN income_statement (annual, 2022-12-31) — Operating Revenue: 26658000.00
PGEN balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 208150021.00
PGEN balance_sheet (annual, 2022-12-31) — Other Current Assets: 5066000.00
PGEN balance_sheet (annual, 2022-12-31) — Other Current Borrowings: 43219000.00
PGEN balance_sheet (annual, 2022-12-31) — Other Equity Adjustments: -3488000.00
PGEN income_statement (annual, 2022-12-31) — Other Income Expense: 1281000.00
PGEN balance_sheet (annual, 2022-12-31) — Other Intangible Assets: 44455000.00
PGEN balance_sheet (annual, 2022-12-31) — Other Inventories: 272000.00
PGEN cash_flow (annual, 2022-12-31) — Other Non Cash Items: -79978000.00
PGEN balance_sheet (annual, 2022-12-31) — Other Non Current Assets: 1148000.00
PGEN income_statement (annual, 2022-12-31) — Other Non Operating Income Expenses: 1539000.00
PGEN balance_sheet (annual, 2022-12-31) — Other Properties: 26092000.00
PGEN balance_sheet (annual, 2022-12-31) — Other Receivables: 12826000.00
PGEN balance_sheet (annual, 2022-12-31) — Other Short Term Investments: 51092000.00
PGEN balance_sheet (annual, 2022-12-31) — Payables: 4068000.00
PGEN balance_sheet (annual, 2022-12-31) — Payables And Accrued Expenses: 27815000.00
PGEN balance_sheet (annual, 2022-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 6377000.00
PGEN cash_flow (annual, 2022-12-31) — Preferred Stock Issuance: 0.00
PGEN income_statement (annual, 2022-12-31) — Pretax Income: -79966000.00
PGEN cash_flow (annual, 2022-12-31) — Proceeds From Stock Option Exercised: 1000.00
PGEN balance_sheet (annual, 2022-12-31) — Properties: 0.00
PGEN cash_flow (annual, 2022-12-31) — Provisionand Write Offof Assets: 944000.00
PGEN cash_flow (annual, 2022-12-31) — Purchase Of Investment: 0.00
PGEN cash_flow (annual, 2022-12-31) — Purchase Of PPE: -4924000.00
PGEN balance_sheet (annual, 2022-12-31) — Raw Materials: 15000.00
PGEN balance_sheet (annual, 2022-12-31) — Receivables: 13804000.00
PGEN income_statement (annual, 2022-12-31) — Reconciled Cost Of Revenue: 6339000.00
PGEN income_statement (annual, 2022-12-31) — Reconciled Depreciation: 10765000.00
PGEN cash_flow (annual, 2022-12-31) — Repayment Of Debt: -155293000.00
PGEN income_statement (annual, 2022-12-31) — Research And Development: 47170000.00
PGEN balance_sheet (annual, 2022-12-31) — Restricted Cash: 43339000.00
PGEN balance_sheet (annual, 2022-12-31) — Retained Earnings: -1868567000.00
PGEN cash_flow (annual, 2022-12-31) — Sale Of Investment: 68441000.00
PGEN income_statement (annual, 2022-12-31) — Selling General And Administration: 48006000.00
PGEN balance_sheet (annual, 2022-12-31) — Share Issued: 208150021.00
PGEN cash_flow (annual, 2022-12-31) — Short Term Debt Issuance: 0.00
PGEN cash_flow (annual, 2022-12-31) — Short Term Debt Payments: 0.00
PGEN income_statement (annual, 2022-12-31) — Special Income Charges: -1120000.00
PGEN cash_flow (annual, 2022-12-31) — Stock Based Compensation: 10206000.00
PGEN balance_sheet (annual, 2022-12-31) — Stockholders Equity: 126259000.00
PGEN balance_sheet (annual, 2022-12-31) — Tangible Book Value: 44881000.00
PGEN income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: -2647.13
PGEN income_statement (annual, 2022-12-31) — Tax Provision: -189000.00
PGEN income_statement (annual, 2022-12-31) — Tax Rate For Calcs: 0.00
PGEN balance_sheet (annual, 2022-12-31) — Total Assets: 215977000.00
PGEN balance_sheet (annual, 2022-12-31) — Total Capitalization: 126259000.00
PGEN balance_sheet (annual, 2022-12-31) — Total Debt: 51420000.00
PGEN balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: 126259000.00
PGEN income_statement (annual, 2022-12-31) — Total Expenses: 101515000.00
PGEN balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 89718000.00
PGEN balance_sheet (annual, 2022-12-31) — Total Non Current Assets: 97818000.00
PGEN balance_sheet (annual, 2022-12-31) — Total Non Current Liabilities Net Minority Interest: 11073000.00
PGEN income_statement (annual, 2022-12-31) — Total Operating Income As Reported: -75726000.00
PGEN income_statement (annual, 2022-12-31) — Total Unusual Items: -1120000.00
PGEN income_statement (annual, 2022-12-31) — Total Unusual Items Excluding Goodwill: -1120000.00
PGEN cash_flow (annual, 2022-12-31) — Unrealized Gain Loss On Investment Securities: 0.00
PGEN balance_sheet (annual, 2022-12-31) — Working Capital: 39514000.00
PGEN income_statement (annual, 2023-12-31) — +Operating Expense: 89029000.00
PGEN income_statement (annual, 2023-12-31) — +Total Revenue: 6225000.00
PGEN balance_sheet (annual, 2023-12-31) — Accounts Payable: 1726000.00
PGEN balance_sheet (annual, 2023-12-31) — Accounts Receivable: 902000.00
PGEN balance_sheet (annual, 2023-12-31) — Accumulated Depreciation: -24283000.00
PGEN balance_sheet (annual, 2023-12-31) — Additional Paid In Capital: 2084916000.00
PGEN balance_sheet (annual, 2023-12-31) — Allowance For Doubtful Accounts Receivable: -184000.00
PGEN cash_flow (annual, 2023-12-31) — Amortization Cash Flow: 4848000.00
PGEN cash_flow (annual, 2023-12-31) — Amortization Of Intangibles: 4848000.00
PGEN cash_flow (annual, 2023-12-31) — Amortization Of Securities: -1809000.00
PGEN cash_flow (annual, 2023-12-31) — Asset Impairment Charge: 10835000.00